Please provide your email address to receive an email when new articles are posted on . Postmenopausal women with moderate to severe genitourinary syndrome experienced small but significant increases ...

Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008;111:67 ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified no link between vaginal estrogen tablet use and recurrent stroke risk. The findings did ...

A total of 3353 recurrent cases were identified from a cohort of 56,642 women with a first-time stroke and were matched with 3353 controls. HealthDay News — For women with a history of ischemic stroke ...

BAUDETTE, Minn., Sept. 12, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for ...

In Danish women with a history of ischemic stroke, use of vaginal estradiol tablets was not associated with an increased rate of recurrent ischemic stroke. Results suggest these women may not be so ...

Yaz (drospirenone/ethinyl estradiol) is a prescription oral tablet that’s used to help prevent pregnancy. It’s also used to treat acne and premenstrual dysphoric disorder in certain people. Yaz ...

NEW YORK (Reuters Health) - An ultra-low dose of 10 micrograms of estradiol significantly improves vaginal tissue, pH balance, and urogenital symptoms in postmenopausal women with vaginal atrophy, new ...

Research shows that estrogen administration, such as through HRT, can increase resting energy expenditure by up to 200-220 ...

SALISBURY, Md.--(BUSINESS WIRE)--Jubilant Cadista Pharmaceuticals Inc. is voluntarily recalling one lot of Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg, 28x3 Blister Pack/Carton to ...

Exposure to vaginal estradiol not linked to increased rate of recurrent ischemic stroke when adjusted for comorbidity, medications, income, education. (HealthDay News) — For women with a history of ...